Pearls for Management of Pso and PsA: a 'Global' Perspective

The discussion focuses on the management of psoriasis (Pso) and psoriatic arthritis (PsA) from a global perspective, particularly highlighting the roles of dermatologists and rheumatologists. Emphasizing the importance of evaluation and early diagnosis, the speaker notes how a delay in identifying PsA can significantly increase the risk of joint damage. The talk introduces GRAPPA (Global Psoriasis and Psoriatic Arthritis Research and Assessment), which provides evidence-based treatment recommendations tailored to various disease domains. The speaker shares clinical cases to illustrate the application of treatment guidelines, noting that most therapies for psoriasis are also effective for PsA, with the exception of topicals and phototherapy. Special attention is given to the effectiveness of different biologics for treating the interplay of skin and joint symptoms, with recommendations changing based on disease severity and patient response. The importance of a comprehensive approach that encompasses screening, teamwork between specialties, and patient-centered care is stressed, especially addressing that PsA can develop even in patients with clear skin from psoriasis. The presentation encourages more collaboration across dermatology and rheumatology, as well as active participation in research organizations like GRAPPA to enhance understanding and treatment of these conditions.